Gland Pharma Limited

NSE GLAND.NS

Gland Pharma Limited Current Liabilities for the year ending March 31, 2024: USD 167.65 M

Gland Pharma Limited Current Liabilities is USD 167.65 M for the year ending March 31, 2024, a 88.98% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Gland Pharma Limited Current Liabilities for the year ending March 31, 2023 was USD 88.71 M, a 15.73% change year over year.
  • Gland Pharma Limited Current Liabilities for the year ending March 31, 2022 was USD 76.65 M, a 9.51% change year over year.
  • Gland Pharma Limited Current Liabilities for the year ending March 31, 2021 was USD 70.00 M, a 46.92% change year over year.
  • Gland Pharma Limited Current Liabilities for the year ending March 31, 2020 was USD 47.64 M, a -37.86% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
NSE: GLAND.NS

Gland Pharma Limited

CEO Mr. Shyamakant Giri
IPO Date Nov. 20, 2020
Location India
Headquarters Plot No. 11 & 84, TSIIC Phase: IV
Employees 4,217
Sector Healthcare
Industries
Description

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Similar companies

CAMS.NS

Computer Age Management Services Limited

USD 41.53

-1.00%

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.88

-0.93%

ROUTE.NS

Route Mobile Limited

USD 13.80

0.71%

LAURUSLABS.NS

Laurus Labs Limited

USD 6.73

-0.82%

ALKEM.NS

Alkem Laboratories Limited

USD 58.36

0.18%

StockViz Staff

February 2, 2025

Any question? Send us an email